Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America

Bone Marrow Transplantation

Volumn 47, Issue 4, 2012, Pages 522-527

  Palma, J ^a   Sasso, D F ^b   Dufort, G ^a   Koop, K ^a   Sampor, C ^a   Diez, B ^c   Richard, L ^d   Castillo, L ^d   Chantada, G L ^a,c  

^a HOSPITAL LUIS CALVO MACKENNA   (Chile)

^b Instituto Argentino de Diagnostico y Tratamiento   (Argentina)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d FLENI   (Argentina)

Author keywords

developing countries; extraocular; retinoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; ETOPOSIDE; THIOPETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; ORBIT METASTASIS; PRIORITY JOURNAL; RETINOBLASTOMA; SCHOOL CHILD; SOUTH AMERICA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHILD, PRESCHOOL; ETOPOSIDE; FEMALE; HUMANS; INFANT; MALE; MELPHALAN; NEOPLASM METASTASIS; RETINOBLASTOMA; SOUTH AMERICA; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84859450514     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.108     Document Type: Article

References (32)

1. MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME et al. Retinoblastoma: treatment and survival in Great Britain 1963-2002. Br J Ophthalmol 2009; 93: 38-39.
2. Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB et al. Survival of retinoblastoma in less-developed countries. Impact of socioeconomic and health-related indicators. Br J Ophthalmol 2010; 94: 1432-1436.
3. Leal-Leal CA, Rivera-Luna R, Flores-Rojo M, Juarez-Echenique JC, Ordaz JC, Amador-Zarco J. Survival in extra-orbital metastatic retinoblastoma: treatment results. Clin Transl Oncol 2006; 8: 39-44.
4. Gunduz K, Muftuoglu O, Gunalp I, Unal E, Tacyildiz N. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology 2006; 113: 1558-1566. (Pubitemid 44292302)
5. Dunkel IJ, Aledo A, Kernan NA, Kushner B, Bayer L, Gollamudi SV et al. Successful treatment of metastatic retinoblastoma. Cancer 2000; 89: 2117-2121.
6. Namouni F, Doz F, Tanguy ML, Quintana E, Michon J, Pacquement H et al. High-dose chemotherapy with carbopla-tin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 1997; 33: 2368-2375. (Pubitemid 28129178)
7. Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, Novaes PE, Chojniak MM, Arias V et al. Extraocular retinoblastoma: a 13-year experience. Cancer 2003; 98: 1292-1298. (Pubitemid 37099915)
8. Chantada G, Fandino A, Davila MT, Manzitti J, Raslawski E, Casak S et al. Results of a prospective study for the treatment of retinoblastoma. Cancer 2004; 100: 834-842. (Pubitemid 38176864)
9. Chantada G, Fandino A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol 2003; 40: 158-161. (Pubitemid 36110277)
10. Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 2006; 47: 801-805. (Pubitemid 44476757)
11. Palma J, Mosso C, Paris C, Campbell M, Tong X, King A et al. Establishment of a pediatric HSCT program in a public hospital in Chile. Pediatr Blood Cancer 2006; 46: 803-810. (Pubitemid 43726430)
12. Chantada GL, Fandino AC, Guitter MR, Raslawski EC, Dominguez JL, Manzitti J et al. Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer 2010; 55: 60-66.
13. Gadner H, Emminger W, Ladenstein R, Peters C High-dose melphalan, etoposide, and carboplatin (MEC) +/-fractionated total body irradiation for treatment of advanced solid tumors. Pediatr Hematol Oncol 1992; 9: v-viii.
14. Dunkel IJ, Chan HS, Jubran R, Chantada GL, Goldman S, Chintagumpala M et al. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer 2010; 55: 149-152.
15. Dunkel IJ, Khakoo Y, Kernan NA, Gershon T, Gilheeney S, Lyden DC et al. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. Pediatr Blood Cancer 2010; 55: 55-59.
16. Rodriguez-Galindo C, Wilson MW, Haik BG, Lipson MJ, Cain A, Merchant TE et al. Treatment of metastatic retinoblastoma. Ophthalmology 2003; 110: 1237-1240. (Pubitemid 36676660)
17. Jubran RF, Erdreich-Epstein A, Butturini A, Murphree AL, Villablanca JG. Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience. J Pediatr Hematol Oncol 2004; 26: 31-34. (Pubitemid 38095632)
18. Kremens B, Wieland R, Reinhard H, Neubert D, Beck JD, Klingebiel T et al. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 2003; 31: 281-284. (Pubitemid 36336231)
19. Dimaras H, Heon E, Budning A, Doyle JJ, Halliday W, Gallie BL et al. Retinoblastoma CSF metastasis cured by multi-modality chemotherapy without radiation. Ophthalmic Genet 2009; 30: 121-126.
20. Matsubara H, Makimoto A, Higa T, Kawamoto H, Sakiyama S, Hosono A et al. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. Bone Marrow Transplant 2005; 35: 763-766. (Pubitemid 40613783)
21. Dunkel IJ, Jubran RF, Gururangan S, Chantada GL, Finlay JL, Goldman S et al. Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer 2010; 54: 384-387.
22. Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet 2009; 30: 31-36.
23. Ladenstein R, Potschger U, Hartman O, Pearson AD, Klingebiel T, Castel V et al. 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures. Bone Marrow Transplant 2008; 41 (Suppl 2): S118-S127. (Pubitemid 351864722)
24. Yalcin B, Kremer LC, Caron HN, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev 2010; 12: CD006301.
25. Durbin M. Bone marrow transplantation: economic, ethical, and social issues. Pediatrics 1988; 82: 774-783. (Pubitemid 18260251)
26. Yamane S, Shirai C, Arimoto A, Komura E, Ohmisono Y, Sawada T. et al. Disseminated retinoblastoma successfully treated with myeloablative chemotherapy-implication for molecular detection of minimal residual disease. Bone Marrow Transplant 1999; 23: 971-974. (Pubitemid 29213704)
27. Meadows AT, Chintagumpala M, Dunkel IJ, Friedman D, Stoner JA, Villablanca JG. Children's oncology group trials for Retinoblastoma. In: Singh A, Damato B, Pe'er J, Murphree AL, Perry JD (eds). Essentials of Ophthalmic Oncology. SLACK Incorporated: Thorofare, 2009, pp 204-205.
28. Ribeiro Kde C, Antoneli CB. Trends in eye cancer mortality among children in Brazil, 1980-2002. Pediatr Blood Cancer 2007; 48: 296-305. (Pubitemid 46238520)
29. Naseripour M, Nazari H, Bakhtiari P, Modarreszadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival. Br J Ophthalmol 2009; 93: 28-32.
30. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1339-1343. (Pubitemid 26398719)
31. Chantada GL, Fandino AC, Raslawski EC, Manzitti J, de Davila MT, Casak SJ et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer 2005; 44: 455-460. (Pubitemid 40614493)
32. Chantada GL, Dunkel IJ, Antoneli CB, de Davila MT, Arias V, Beaverson K et al. Risk factors for extraocular relapse following enucleation after failure of chemo-reduction in retinoblastoma. Pediatr Blood Cancer 2007; 49: 256-260. (Pubitemid 47236213)